Monte Rosa Therapeutics, Inc. (GLUE) › RevenueMonte Rosa Therapeutics, Inc. (GLUE) — RevenueAnnual figures by fiscal year, from SEC filings.2023: $02024: $75.62M2025: $123.67M$123.67M2023Revenue (USD)2025Fiscal YearRevenueChange YoY2025$123.67M+63.5%2024$75.62M—2023$0—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share